MENLO PARK, Calif. & EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--April 26, 2006--Depomed, Inc. (NASDAQ:DEPO - News) and Esprit Pharma, Inc. announced today that Once-Daily ProQuin®XR, the new, prolonged release once-daily formulation of ciprofloxacin hydrochloride for the treatment of uncomplicated urinary tract infections (uUTI), is now available in 3-tablet blister packs, in addition to the original launch packaging of a bottle of 50 tablets. Esprit’s 190-person sales and managed care organization are actively calling on physician offices and retail pharmacies nationwide.
